Quick Answer
Iterum Therapeutics plc reported Stockholders Equity of -$4.08 million for fiscal year 2024.
Iterum Therapeutics plc Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | -$4.08M | +36.3% |
| 2023 | -$6.40M | -122.9% |
| 2022 | $28.00M | -44.3% |
| 2021 | $50.23M | +199.4% |
| 2020 | -$50.56M | -92.7% |
| 2019 | -$26.24M | -136.6% |
| 2018 | $71.62M | +81.3% |
| 2017 | $39.49M | +74.2% |
| 2016 | $22.67M | +51.6% |
| 2015 | $14.95M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$7.38M | +35.9% | -89.9% |
| June 30, 2025 | -$3.89M | +64.4% | -52.2% |
| March 31, 2025 | -$2.55M | +58.5% | +37.4% |
| December 31, 2024 | -$4.08M | +36.3% | +64.5% |
| September 30, 2024 | -$11.51M | -435.3% | -5.4% |
| June 30, 2024 | -$10.91M | -253.1% | -77.4% |
| March 31, 2024 | -$6.15M | -132.4% | +4.0% |
| December 31, 2023 | -$6.40M | -122.9% | -286.6% |
- Iterum Therapeutics plc showed an increase of +36.3% in Stockholders Equity compared to the prior fiscal year.
- Over the 2015–2024 period, Iterum Therapeutics plc’s stockholders equity has declined by 127.3% (from $14.95 million to -$4.08 million).
- The most recent figure is from Iterum Therapeutics plc’s fiscal year 2024 report (Form 10-K), filed with the SEC on February 7, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: